Physician

Charles L Dietzek, D.O.

According to 2025 Medicare claims, Charles Dietzek, D.O. (NPI: 1639283344) practices vascular surgery in the Camden, NJ market, with the plurality of this provider's patient population coming from Camden, NJ. This provider's primary affiliated billing organization is CHARLES L DIETZEK, DO, FACOS, PC (NPI: 1306905658; TIN: 201447409) and primary practice location at 08043-2157.

Dietzek's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 328 traditional Medicare patients, billed 1,223 HCPCS/CPT codes, and received $135,650 in Medicare payments. The top billing code was 93970 (Ultrasound study of arm or leg veins with compression and maneuvers). Part D data shows 80 prescription claims across 37 beneficiaries totaling $38,825 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 4 records totaling $170. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $416,566 to $135,650. In contrast, Part D prescription costs have moved from a lower plateau to a higher plateau, from $7,061 to $38,825. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$208K$417K2015 Medicare payment: $416,566 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $383,137 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $403,054 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $386,604 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $366,893 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $276,162 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $273,178 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $231,955 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $277,839 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $135,650 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20155751,897$416,566
20165631,847$383,137
20175961,958$403,054
20185321,744$386,604
20195091,707$366,893
20203361,301$276,162
20213701,351$273,178
20223101,298$231,955
20233001,467$277,839
20243281,223$135,650

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$19K$39K2015 Drug cost: $7,061 (USD; Tot_Drug_Cst)2016 Drug cost: $5,730 (USD; Tot_Drug_Cst)2017 Drug cost: $12,015 (USD; Tot_Drug_Cst)2018 Drug cost: $17,098 (USD; Tot_Drug_Cst)2019 Drug cost: $30,779 (USD; Tot_Drug_Cst)2020 Drug cost: $22,886 (USD; Tot_Drug_Cst)2021 Drug cost: $22,034 (USD; Tot_Drug_Cst)2022 Drug cost: $31,696 (USD; Tot_Drug_Cst)2023 Drug cost: $24,574 (USD; Tot_Drug_Cst)2024 Drug cost: $38,825 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20153064$7,061
20162361$5,730
20172554$12,015
20183658$17,098
20193872$30,779
20202762$22,886
20212655$22,034
20223485$31,696
20233486$24,574
20243780$38,825

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
93970Ultrasound study of arm or leg veins with compression and maneuvers201219$141
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more209209$113
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more5355$93
93971Ultrasound study of one arm or leg veins with compression and maneuvers149279$91
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more143301$67

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
EliquisApixaban461,890$37,466

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.4$170E.R. Squibb & Sons, L.L.C.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Charles L. Dietzek, D.O.?

Tedicare shows public-source Medicare data for Charles L. Dietzek, D.O. (NPI 1639283344), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Charles L. Dietzek, D.O. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Charles L. Dietzek, D.O.?

Charles L. Dietzek, D.O. is linked to CHARLES L DIETZEK, DO, FACOS, PC (billing NPI 1306905658) in the available physician profile data.

Does Charles L. Dietzek, D.O. have Open Payments data?

Charles L. Dietzek, D.O. has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.